243 related articles for article (PubMed ID: 23176887)
21. Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.
Higham MA; Sharara AM; Wilson P; Jenkins RJ; Glendenning GA; Ind PW
Thorax; 1997 Nov; 52(11):975-80. PubMed ID: 9487346
[TBL] [Abstract][Full Text] [Related]
22. Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials.
Haney S; Hancox RJ
Respir Res; 2007 Mar; 8(1):19. PubMed ID: 17341317
[TBL] [Abstract][Full Text] [Related]
23. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma.
Simons FE; Soni NR; Watson WT; Becker AB
J Allergy Clin Immunol; 1992 Nov; 90(5):840-6. PubMed ID: 1358932
[TBL] [Abstract][Full Text] [Related]
24. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
Cockcroft DW; Swystun VA; Bhagat R
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1485-9. PubMed ID: 7582281
[TBL] [Abstract][Full Text] [Related]
25. Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics.
Wong AG; O'Shaughnessy AD; Walker CM; Sears MR
Eur Respir J; 1997 Feb; 10(2):330-6. PubMed ID: 9042628
[TBL] [Abstract][Full Text] [Related]
26. Tolerance to the bronchoprotective effect of beta2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo.
Cockcroft DW; Davis BE; Swystun VA; Marciniuk DD
J Allergy Clin Immunol; 1999 Jun; 103(6):1049-53. PubMed ID: 10359885
[TBL] [Abstract][Full Text] [Related]
27. Reduced dose salbutamol in comparison with standard dosage for symptom relief in asthma.
Yates DH; Peters MJ; Keatings V; Thomas PS; Barnes PJ
Eur Respir J; 1995 Nov; 8(11):1847-51. PubMed ID: 8620950
[TBL] [Abstract][Full Text] [Related]
28. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
[TBL] [Abstract][Full Text] [Related]
29. Tolerance to beta-agonists during acute bronchoconstriction.
Hancox RJ; Aldridge RE; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Town GI; Taylor DR
Eur Respir J; 1999 Aug; 14(2):283-7. PubMed ID: 10515402
[TBL] [Abstract][Full Text] [Related]
30. Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo.
Cheung D; Wever AM; de GOEIJ JA; de GRAAFF CS; Steen H; Sterk PJ
Am J Respir Crit Care Med; 1998 Sep; 158(3):792-6. PubMed ID: 9731006
[TBL] [Abstract][Full Text] [Related]
31. Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma.
Irwin RS; French CT; Smyrnios NA; Curley FJ
Arch Intern Med; 1997 Sep; 157(17):1981-7. PubMed ID: 9308510
[TBL] [Abstract][Full Text] [Related]
32. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
[TBL] [Abstract][Full Text] [Related]
33. Regular inhaled salbutamol and airway responsiveness to allergen.
Cockcroft DW; McParland CP; Britto SA; Swystun VA; Rutherford BC
Lancet; 1993 Oct; 342(8875):833-7. PubMed ID: 8104272
[TBL] [Abstract][Full Text] [Related]
34. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
[TBL] [Abstract][Full Text] [Related]
35. Time course of methacholine induced bronchoconstriction during drugs and spontaneous resolution.
Mannino F; Anticoli S; De Luca A; Terzano C
Allergol Immunopathol (Madr); 1996; 24(2):70-4. PubMed ID: 8933892
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of inhaled formoterol in reversing bronchoconstriction.
Rubin AS; Perin C; Pelegrin L; Fernandes JC; da Silva LC
J Bras Pneumol; 2006; 32(3):202-6. PubMed ID: 17273608
[TBL] [Abstract][Full Text] [Related]
37. Duration of bronchoprotection of inhaled ipratropium against inhaled methacholine.
Illamperuma C; Davis BE; Fenton ME; Cockcroft DW
Ann Allergy Asthma Immunol; 2009 May; 102(5):438-9. PubMed ID: 19496252
[No Abstract] [Full Text] [Related]
38. Effects of treatment with formoterol on bronchoprotection against methacholine.
Lipworth B; Tan S; Devlin M; Aiken T; Baker R; Hendrick D
Am J Med; 1998 May; 104(5):431-8. PubMed ID: 9626025
[TBL] [Abstract][Full Text] [Related]
39. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
Lipworth BJ; Dempsey OJ; Aziz I
Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
[TBL] [Abstract][Full Text] [Related]
40. Bronchodilator effect of Ipraterol on methacholine-induced bronchoconstriction in asthmatic patients.
Maneechotesuwan K; Suthamsmai T; Ratanasaenglert K; Pipopsuthipaiboon S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S66-71. PubMed ID: 21728272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
